Valuation: Amedica Corporation

Market Cap 60.47L 53.11L 49.39L 45.32L 85.16L 58Cr 86.47L 5.87Cr 2.29Cr 29Cr 2.27Cr 2.22Cr 99Cr P/E 2026 *
-0.65x
P/E 2027 * -0.98x
Enterprise Value 60.47L 53.11L 49.39L 45.32L 85.16L 58Cr 86.47L 5.87Cr 2.29Cr 29Cr 2.27Cr 2.22Cr 99Cr EV / Sales 2026 *
2.63x
EV / Sales 2027 * 1.15x
Free-Float
65.08%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 01/12/2007
President - 16/03/2026
Director of Finance/CFO 41 04/09/2025
Director TitleAgeSince
Director/Board Member 63 01/12/2007
Director/Board Member 63 03/04/2025
Director/Board Member 72 05/11/2012
Change 5-day change 1-year change 3-year change Capi.($)
-7.92%-7.29% - - 60.47L
+3.54%+3.25%-18.16%+13.52% 13TCr
+1.92%-0.96%-2.85%-4.52% 1.28TCr
+0.95%-2.07%+62.86%+106.79% 901.61Cr
-6.12%-1.94%-48.53%-70.40% 438.94Cr
-0.21%-2.71%-1.65%+36.76% 262.55Cr
-2.59%-0.76%-20.35%-25.38% 158.84Cr
-3.05%-2.46%-27.45%-34.57% 157.87Cr
+3.72%-0.15%-1.85%-57.71% 155.59Cr
Average -1.08%-1.82%-7.25%-4.44% 2TCr
Weighted average by Cap. +2.81%+2.14%-12.89%+13.86%

Financials

2026 *2027 *
Net sales 23.04L 20.23L 18.81L 17.27L 32.44L 22Cr 32.94L 2.23Cr 87.29L 11Cr 86.47L 84.61L 38Cr 52.67L 46.26L 43.02L 39.48L 74.18L 51Cr 75.32L 5.11Cr 2Cr 25Cr 1.98Cr 1.93Cr 86Cr
Net income -1.24Cr -1.09Cr -1.01Cr -92.78L -1.74Cr -119.21Cr -1.77Cr -12Cr -4.69Cr -59Cr -4.65Cr -4.55Cr -202.63Cr -1.14Cr -99.92L -92.92L -85.27L -1.6Cr -109.56Cr -1.63Cr -11Cr -4.31Cr -54Cr -4.27Cr -4.18Cr -186.23Cr
Net Debt - -
Logo Amedica Corporation
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-